JAGX ▲ +9.7% - Jaguar Health, Inc. $JAGX - Jaguar Health Receives Fee Waivers from FDA Jaguar Health climbed 9.7% after receiving fee waivers from the FDA, a development that reduces regulatory costs and signals FDA engagement with the company's drug candidates. Fee waivers typically indicate the agency views a company's programs as viable enough to warrant streamlined review, which can accelerate timelines and lower development expenses. 22-SEP-2026 09:05 AM ET